Navigation Links
Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
Date:2/8/2008

atients and the two other trials are expected to begin soon. Bavituximab is also in clinical trials in the U.S. in patients co-infected with HCV and HIV.

Dr. Stopeck's presentation, "Phase I Clinical Studies of the Anti-Tumor Vasculature Antibody, Bavituximab," is part of the Angio 2008 session on Early Drug Development/Clinical Trial Results being held from 8:00 am to 12:00 pm PST at the 10th Annual International Symposium on Anti-Angiogenic Agents at the Hyatt Regency Hotel in La Jolla, CA.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that results of future clinical trials will not correlate with the results of earlier phase I trials and preclinical studies. It is important to note that the company's actual results could differ materi
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
2. IDX899 Demonstrates Rapid and Profound Inhibition of HIV Replication in a Phase I/II Clinical Trial in Treatment-Naive HIV-Infected Patients
3. Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
4. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
5. Multiple Dose Clinical Trial of TorreyPines Therapeutics Tezampanel Demonstrates Compound is Safe and Well-Tolerated
6. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
7. PTC Therapeutics Announces Publication of Preclinical Data in PNAS
8. Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market
9. Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Trial
10. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
11. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... and LOS ANGELES , Aug. ... DGX ), the world,s leading provider of diagnostic ... the previously announced acquisition of MemorialCare Health System,s ... a result of the transaction, patients and physicians ... innovative services and network of nearly 200 patient ...
(Date:8/4/2015)... , Aug. 4, 2015  The Pittsburgh Life Sciences ... firm, announced today that one of its portfolio companies, ... their Flex ® Robotic System in the U.S.  ... more proud of Medrobotics," said John W. Manzetti ... a very long way since spinning out of The ...
(Date:8/4/2015)... 4, 2015  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... $18.9 million for the three and six months ended ... of $12.1 million and $43.4 million for the same ... driven primarily by the more than $90 million of ... the upfront payment from Bayer to license  ISIS-FXI Rx ...
Breaking Medicine Technology:Quest Diagnostics Completes Acquisition of MemorialCare Health System's Laboratory Outreach Service Business in Southern California 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16
(Date:8/4/2015)... Dublin, Ohio (PRWEB) , ... August 04, 2015 , ... ... days of summer in the sun and preparing for the back-to-school scramble. Dublin, ... of summer is the best time for the annual dental checkup. In fact, the ...
(Date:8/4/2015)... ... 2015 , ... Members receiving care from a doctor who participates in a ... is nine percent lower -- than those members at traditional doctor practices, according to ... , “The promise of patient-centered, or value-based, care to deliver better quality care ...
(Date:8/4/2015)... San Francisco, Calif. (PRWEB) , ... August 04, ... ... services to corporations, law firms and government entities, today announced that John Munro, ... leadership team as Vice President of Managed Services Operations. , “I am thrilled ...
(Date:8/4/2015)... Montclair, NJ (PRWEB) , ... August 04, 2015 , ... ... in Arts and Health, the first of its kind in New Jersey, which starting ... College of the Arts and Graduate School partnered with Atlantic Health System, one of ...
(Date:8/4/2015)... ... August 04, 2015 , ... A new report by ... reseller channel will grow at least 6 percent in 2015, as solution providers ... greater than their OEM/vendor partners. , The 2112 Group’s 2015 Midyear Channel ...
Breaking Medicine News(10 mins):Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 2Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 4Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 3Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3
... vegetables, coffee, tea and chocolate, could slash the risk ... ,The prospective cohort study of 34,489 postmenopausal ... Journal of Clinical Nutrition, reports that high dietary intake ... of mortality from cardiovascular disease (CVD), coronary heart disease ...
... may sometimes cause a bizarre but dangerous side effect -- sleep-driving, the ... ,Those who take the pills could go on to drive cars ... taken a tablet at all. ,Also they could ... asleep, not realizing that are yet to wake up. ,Still ...
... concern about the paucity of donor bodies, which is a ... to teach anatomy to medical students. ... a 30% shortage in the number of bodies. ... encourage their patients to donate their bodies for the cause ...
... some tough time on the health front, especially on account// ... it stood on the brink of an explosive AIDS epidemic. ... number of HIV infected people could soar to 10 millions ... effective action. ,The oil-rich Xinjiang Uygur Autonomous Region ...
... be launching a major initiative to reduce infant mortality ... been announced. ,Under the scheme called The ... volunteers, along with doctors and nurses, will be given ... Health Ministry official. ,Under the scheme Accredited ...
... wipe out memories selectively from the human brain. Researchers are ... to wipe out a single specific memory from brains of ... ,If that experiment can be successfully replicated in ... help relieve sufferers of the Post-traumatic Stress Disorder (PTSD). ...
Cached Medicine News:Health News:Science Stacks Up for Flavonoids for Heart Health 2Health News:Science Stacks Up for Flavonoids for Heart Health 3
... Premier Encore's balanced, iso-centered c-arm ... device is easy to position ... Controls on the x-ray tube ... and wireless remote control provide ...
The KM-500's unique viewing and alignment window lets you observe the targeted eye from any distance. Two rechargeable batteries provide continuous uninterrupted use. Each battery provides 60 minutes...
Non-dissolvable Herrick Lacrimal Plugs provide long-term lacrimal occlusion through partial blockage of the horizontal canaliculus....
... quick freezing and quick defrosting ... system - cleans the probes ... probe tips have high conductivity ... Detachment, Glaucoma and Intra-vitreal surgery. ...
Medicine Products: